Yoghurt Consumption, Body Weight Management and Glycemic Control of T2DM Patients

NCT ID: NCT03926806

Last Updated: 2019-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-25

Study Completion Date

2018-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates the effects of consumption of yoghurt enriched with vitamins B compared to plain yoghurt, on body weight management and glycemic control of overweight/obese T2DM patients. It also investigates the effect of plain yoghurt consumption on gut hormones response of T2DM patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In a large number of epidemiological studies, low-fat dairy consumption has been associated with lower risk of T2DM. However, the number of randomized clinical trials which examine the impact of yoghurt consumption on glycemic control and body weight management of T2DM patients is small and include yoghurts fortified with vitamin D or probiotics. According to our knowledge, fortification of yoghurt with other classes of vitamins beyond vitamin D has not been examined. Vitamins of B-complex hold key-role in energy metabolism. In the state of diabetes mellitus, the requirements for this vitamin class may be higher because of their water solubility and increased excretion. Two groups of patients participated in the study. One group received yoghurt enriched with vitamins B and one group received isocaloric plain yoghurt. In addition, in order to investigate the effect of plain yoghurt on gut hormones, responses to a mixed meal tolerance test were evaluated in the beggining and the end of the dietary intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel assignment
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plain yoghurt

2x200g plain yoghurt/day for 12 weeks

Group Type ACTIVE_COMPARATOR

Plain yoghurt

Intervention Type OTHER

cups of 200 g yoghurt

Vitamin B yoghurt

2x200g yoghurt enriched with vitamins B for 12 weeks

Group Type EXPERIMENTAL

Vitamin B yoghurt

Intervention Type OTHER

cups of 200 g yoghurt

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plain yoghurt

cups of 200 g yoghurt

Intervention Type OTHER

Vitamin B yoghurt

cups of 200 g yoghurt

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Conventional yoghurt

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI 27-36
* HbA1C \< 8.5%
* Constant body weight and dietary habits for the last 3 months
* Stable dose of oral medication for at least 3 months
* Diagnosed with T2DM for more than 1 year

Exclusion Criteria

* History of cardiovascular, gastrointestinal, renal and endocrinological diseases
* Treatment for weight reduction
* Lactose intolerance
* Allergies to milk and dairy products
* Alcohol consumption (\> 2 drinks per day)
* Intake of supplements
* Receiving insulin
Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National and Kapodistrian University of Athens

OTHER

Sponsor Role collaborator

Harokopio University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amalia Yanni

Research and Teaching Associate-Staff

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amalia Yanni

Role: PRINCIPAL_INVESTIGATOR

Harokopio University

Nikolaos Tentolouris

Role: STUDY_CHAIR

National and Kapodistrian University of Athens

Vaios Karathanos

Role: STUDY_DIRECTOR

Harokopio University

References

Explore related publications, articles, or registry entries linked to this study.

Panahi S, Tremblay A. The Potential Role of Yogurt in Weight Management and Prevention of Type 2 Diabetes. J Am Coll Nutr. 2016 Nov-Dec;35(8):717-731. doi: 10.1080/07315724.2015.1102103. Epub 2016 Jun 22.

Reference Type BACKGROUND
PMID: 27332081 (View on PubMed)

Kaur B, Henry J. Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res. 2014;71:55-100. doi: 10.1016/B978-0-12-800270-4.00002-X.

Reference Type BACKGROUND
PMID: 24484939 (View on PubMed)

El Khoury D, Brown P, Smith G, Berengut S, Panahi S, Kubant R, Anderson GH. Increasing the protein to carbohydrate ratio in yogurts consumed as a snack reduces post-consumption glycemia independent of insulin. Clin Nutr. 2014 Feb;33(1):29-38. doi: 10.1016/j.clnu.2013.03.010. Epub 2013 Mar 27.

Reference Type BACKGROUND
PMID: 23591152 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1354.18-11-16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.